0000784199-24-000059.txt : 20240228
0000784199-24-000059.hdr.sgml : 20240228
20240228170134
ACCESSION NUMBER: 0000784199-24-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stanton Marshall S.
CENTRAL INDEX KEY: 0001849615
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13165
FILM NUMBER: 24696576
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BLVD, NW
CITY: KENNESAW
STATE: GA
ZIP: 30144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARTIVION, INC.
CENTRAL INDEX KEY: 0000784199
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 592417093
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
BUSINESS PHONE: 7704193355
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOLIFE INC
DATE OF NAME CHANGE: 19940526
4
1
wk-form4_1709157669.xml
FORM 4
X0508
4
2024-02-23
0
0000784199
ARTIVION, INC.
AORT
0001849615
Stanton Marshall S.
1655 ROBERTS BLVD., NW
KENNESAW
GA
30144
0
1
0
0
SVP, Clinical & MD Affair
0
Common Stock
2024-02-23
4
A
0
5386
0
A
74089
D
Common Stock
2024-02-26
4
S
0
1600
20.2711
D
72489
D
Common Stock
2024-02-23
4
A
0
10644
0
A
83133
D
Common Stock
2024-02-26
4
S
0
1448
20.2711
D
81685
D
Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date
/s/ Marshall Stanton
2024-02-28